BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Short Interest Update
MarketBeat
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT - Get Free Report) saw a large drop in short interest in September. As of September 15th, there was short interest totaling 3,595,979 shares, a drop of 41.9% from the August 31st total of 6,193,538 shares. Based on an average daily volume of 824,822 shares, the short-interest ratio is presently 4.4 days. Currently, 5.9% of the company's stock are sold short.
NASDAQ:BBOT